TCM Valuation
| TCM Stock | DKK 74.60 0.80 1.06% |
At this time, the entity appears to be undervalued. TCM Group has a current Real Value of kr84.78 per share. The regular price of the entity is kr74.6. Our model measures the value of TCM Group from examining the entity fundamentals such as Current Valuation of 914.81 M, return on asset of 0.0757, and Return On Equity of 0.18 as well as evaluating its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that TCM's price fluctuation is very steady at this time. Calculation of the real value of TCM Group is based on 3 months time horizon. Increasing TCM's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TCM is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TCM Stock. However, TCM's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 74.6 | Real 84.78 | Hype 74.6 | Naive 72.3 |
The intrinsic value of TCM's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence TCM's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of TCM Group helps investors to forecast how TCM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TCM more accurately as focusing exclusively on TCM's fundamentals will not take into account other important factors: TCM Total Value Analysis
TCM Group is at this time expected to have takeover price of 914.81 M with market capitalization of 651.94 M, debt of 27.82 M, and cash on hands of 125.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the TCM fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
914.81 M | 651.94 M | 27.82 M | 125.86 M |
TCM Investor Information
About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TCM Group recorded earning per share (EPS) of 7.08. The entity last dividend was issued on the 6th of April 2022. TCM Group is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.TCM Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TCM has an asset utilization ratio of 122.15 percent. This suggests that the Company is making kr1.22 for each dollar of assets. An increasing asset utilization means that TCM Group is more efficient with each dollar of assets it utilizes for everyday operations.TCM Ownership Allocation
The market capitalization of TCM is kr651.94 Million. Over half of TCM's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Therefore, these institutions are subject to different rules and regulations than regular investors in TCM Group. Please watch out for any change in the institutional holdings of TCM as this could mean something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the entity is less than the current market value, you may not be able generate positive returns on investment in the long run.TCM Profitability Analysis
The company reported the revenue of 1.11 B. Net Income was 110.71 M with profit before overhead, payroll, taxes, and interest of 254.6 M.About TCM Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of TCM Group. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of TCM Group based exclusively on its fundamental and basic technical indicators. By analyzing TCM's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of TCM's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of TCM. We calculate exposure to TCM's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TCM's related companies.TCM Group AS engages in the manufacture and sale of kitchen and furniture products for bathrooms and storage in Denmark and internationally. TCM Group AS was founded in 2015 and is headquartered in Holstebro, Denmark. TCM Group operates under Furnishings, Fixtures Appliances classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 483 people.
8 Steps to conduct TCM's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates TCM's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct TCM's valuation analysis, follow these 8 steps:- Gather financial information: Obtain TCM's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine TCM's revenue streams: Identify TCM's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research TCM's industry and market trends, including the size of the market, growth rate, and competition.
- Establish TCM's growth potential: Evaluate TCM's management, business model, and growth potential.
- Determine TCM's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate TCM's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in TCM Stock
TCM financial ratios help investors to determine whether TCM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TCM with respect to the benefits of owning TCM security.